{
    "code": "52026611",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026611",
    "time": "2020-12-18 03:16:04",
    "許可證字號": "衛部藥輸字第026611號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/12\/11",
    "發證日期": "104\/12\/11",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202661105",
    "中文品名": "捷復寧注射劑600毫克",
    "英文品名": "Zinforo 600 mg powder for concentrate for solution for infusion",
    "適應症": "適用於治療新生兒、嬰兒、兒童、青少年及成人對ceftaroline fosamil具感受性菌種的社區性肺炎(CAP)及複雜性皮膚與軟組織感染(cSSTI)。",
    "劑型": "240乾粉注射劑",
    "包裝": "600毫克(type I glass)玻璃小瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "109\/12\/11",
    "主成分略述": "Ceftaroline fosamil",
    "限制項目": "02輸　入 51免除銜接性臨床試驗",
    "申請商名稱": "1504401100  輝瑞大藥廠股份有限公司",
    "申請商地址": "台北市信義區松仁路100號42、43樓",
    "主製造廠": [
        {
            "製造廠名稱": "FIT0395100  ACS DOBFAR S.P.A.",
            "製造廠廠址": "Viale Addetta ,2a\/12-3\/5, TRIBIANO 20067 ITALY",
            "製造廠公司地址": "",
            "製造廠國別": "ITALY",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FIT0456100  ACS DOBFAR S.P.A",
            "製造廠廠址": "NUCLEO INDUSTRIALE S. ATTO, 64100, TERAMO, ITALY",
            "製造廠公司地址": "",
            "製造廠國別": "ITALY",
            "製程": "分包裝廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812310200",
            "成分名稱": "Ceftaroline fosamil",
            "含量描述": "(Equivalent to ceftaroline fosamil acetic acid Solvate monohydrate...668.4MG)",
            "含量": "600.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Zinforo 實體外觀-107-06-08(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026611&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Zinforo LLD 600 mg CDS 20200303-2 (更新檔案properties)-109-10-23(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026611&Seq=009&Type=9"
        },
        {
            "title": "Zinforo LLD 600 mg CDS 20200303-2 (neonate and 5min)_To TFDA-109-10-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026611&Seq=007&Type=9"
        },
        {
            "title": "Zinforo 外盒包裝_公司地址變更-109-10-23(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026611&Seq=008&Type=8"
        },
        {
            "title": "Zinforo 外盒包裝_LENC & civic number change-109-03-09(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026611&Seq=006&Type=8"
        },
        {
            "title": "Zinforo 外盒包裝-107-06-08(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026611&Seq=005&Type=8"
        },
        {
            "title": "026611-Zinforo捷復寧注射劑-標籤-105-02-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026611&Seq=002&Type=8"
        }
    ]
}